Form 4: Amgen SVP, Human Resources, Derek Miller, Reports Stock and Option Grants

Derek Miller, SVP of Human Resources at Amgen, reports the acquisition of stock and option awards.

Summary

• On May 7, 2024, Derek Miller, SVP of Human Resources at Amgen, reported transactions involving Amgen's common stock and non-qualified stock options.
• Miller acquired 865 shares of common stock and 5,624 non-qualified stock options.
• The stock options have an exercise price of $300.30 and vest in three annual installments starting May 7, 2026.
• The restricted stock units (RSUs) also vest in three annual installments starting May 7, 2026.
• Following the reported transactions, Miller beneficially owns 8,983 shares of Amgen common stock and 11,248 non-qualified stock options.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't contain information that would significantly impact sentiment positively or negatively.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. These filings are common across publicly traded companies and are used to monitor insider trading.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are standard practice in the biotechnology industry to incentivize performance and retain talent.
• Companies like Regeneron, Gilead Sciences, and Biogen also utilize similar equity-based compensation plans for their executives.
• The vesting schedules and exercise prices are generally aligned with industry norms to ensure long-term commitment and value creation.

Stakeholder Impact

• The equity grants align management's interests with shareholders, potentially driving long-term value creation.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates